Unexplained vomiting can be overwhelming and frightening—especially when it strikes out of the blue after regular marijuana use. For some individuals, symptoms like persistent nausea, stomach pain, and severe vomiting point to a condition known as Cannabinoid Hyperemesis Syndrome (CHS), classified under ICD-10 medical diagnostic codes.
If you’ve been experiencing these symptoms or are searching for answers for a loved one, know that you’re not alone. At Enlightened Recovery Detox, we aim to provide education, support, and compassionate care for anyone dealing with cannabis-related health concerns. Understanding what’s happening in your body and knowing when to seek help can be a powerful first step in finding relief and restoring balance.
CHS is a relatively new and complex condition—but one that has become increasingly recognized, especially as more potent cannabis products emerge. Emergency room visits attributed to cannabis-associated vomiting disorders have risen dramatically in recent years, linked to higher use rates and increased THC concentrations (Sorensen et al., 2017). Below, we explain what cannabinoid hyperemesis syndrome ICD 10 is, explore its causes and symptoms, and share how Enlightened Recovery Detox can offer healing and hope through personalized care.
What Is Cannabinoid Hyperemesis Syndrome (CHS)?
Cannabinoid Hyperemesis Syndrome is a condition associated with long-term or heavy cannabis use that disrupts how the digestive and nervous systems respond to marijuana. Paradoxically, while cannabis is often known for its nausea-relieving properties in medical treatments, frequent and prolonged use can lead to a breakdown in the body’s ability to regulate digestion, resulting in cyclical episodes of nausea, abdominal pain, and violent vomiting.
How Does CHS Develop?
Researchers believe that CHS develops due to overstimulation of specific receptors in the body called cannabinoid receptors, which are found in both the brain and the gastrointestinal (GI) tract. These receptors regulate critical functions like digestion, appetite, and nausea responses.
When someone uses cannabis heavily or over an extended period, their endocannabinoid system becomes overstimulated, disrupting the natural communication between the brain and digestive organs. This overstimulation can lead to abnormal vomiting signals, resulting in the characteristic episodes of CHS.
These episodes typically have three phases:
- Prodromal Phase: The individual may experience early, mild symptoms like stomach discomfort, nausea, or loss of appetite.
- Hyperemetic Phase: Symptoms escalate to severe vomiting, dehydration, and abdominal pain, often leading to ER visits.
- Recovery Phase: Symptoms improve after cannabis use is stopped, though they may re-emerge with further exposure.
One unique behavioral clue in identifying CHS is the use of hot showers or baths for temporary symptom relief. Many individuals with CHS instinctually report long showers as one of the few ways to ease nausea. This specific behavior stands out clinically and frequently helps physicians differentiate CHS from other GI disorders.
Symptoms of Cannabinoid Hyperemesis Syndrome
Recognizing the symptoms of CHS can help individuals seek medical attention earlier, preventing symptoms from escalating. CHS often starts subtly but progressively worsens, causing significant physical and emotional distress.
Common Symptoms Include:
- Persistent nausea that lasts for hours or days.
- Uncontrollable vomiting that can occur multiple times in a single day.
- Severe stomach cramps or abdominal pain.
- Loss of appetite, leading to noticeable weight loss.
- Dehydration due to excessive vomiting, sometimes leading to confusion or dizziness.
Because CHS symptoms mirror those of other digestive or metabolic disorders, diagnosing CHS requires:
- A detailed review of cannabis use history.
- Documentation under cannabinoid hyperemesis syndrome ICD 10 (diagnostic code F12.288, identifying the impact of long-term cannabis use).
- Ruling out other potential GI conditions using lab work, imaging, or endoscopy.
If symptoms improve after stopping marijuana, it strongly suggests CHS as the underlying condition.
ICD-10 Classification for Cannabinoid Hyperemesis : Why Does It Matter?
The ICD-10 (International Classification of Diseases, 10th Revision) is a globally recognized system used by healthcare providers to classify and document diseases, medical conditions, and related health concerns. By assigning standardized diagnostic codes, ICD-10 helps ensure that patients receive accurate diagnoses and appropriate treatment while allowing healthcare systems to collect reliable health data. Cannabinoid Hyperemesis Syndrome (CHS) is generally documented under the broader category of cannabis-related disorders, including code F12.288 when clinically appropriate.
Accurate ICD-10 coding is important for several reasons:
- Improves Recognition: Standardized coding helps emergency physicians, primary care providers, and specialists identify and document CHS more consistently. Because CHS symptoms often resemble other gastrointestinal conditions, proper documentation can reduce delays in diagnosis and help patients receive appropriate care sooner.
- Supports Treatment Planning: Once CHS is accurately identified, healthcare providers can focus on the underlying cause rather than repeatedly treating only the symptoms. This allows clinicians to educate patients about the connection between chronic cannabis use and recurrent vomiting while developing a comprehensive treatment plan that addresses both symptom management and long-term recovery.
- Tracks Public Health Trends: Consistent ICD-10 coding allows researchers and public health organizations to monitor the prevalence of CHS, evaluate how changing cannabis laws and increasing THC potency affect health outcomes, and identify emerging patterns across different populations.
- Enhances Communication: ICD-10 provides a common language for physicians, hospitals, researchers, insurance providers, and public health agencies. Standardized documentation improves continuity of care, particularly when patients receive treatment from multiple healthcare providers or require referrals to specialists.
- Supports Insurance and Medical Documentation: Accurate coding is also essential for medical records, insurance claims, and healthcare reporting. Proper documentation helps ensure patients receive appropriate coverage for medically necessary evaluations and treatment while creating a complete clinical history for future care.
Cannabis use continues to increase throughout the United States and cannabis products become more potent. Thus, standardized diagnostic frameworks like ICD-10 play an increasingly important role in helping healthcare professionals recognize, document, and study Cannabinoid Hyperemesis Syndrome. Improved recognition not only benefits individual patients but also contributes to a better understanding of the long-term health effects associated with chronic cannabis use.
Why Are CHS Cases Increasing?
As cannabis use becomes more widespread and products continue to increase in potency, healthcare providers are diagnosing Cannabinoid Hyperemesis Syndrome (CHS) more frequently than ever before. While researchers continue to study why some long-term cannabis users develop CHS and others do not, several factors have contributed to the growing number of reported cases. Understanding these trends can help individuals recognize the risks associated with chronic cannabis use and seek appropriate medical care when symptoms arise.
The Role of High-THC Cannabis
Modern cannabis products are significantly stronger than those used decades ago, with some concentrates containing upward of 90% THC compared to traditional marijuana’s 5–20% THC content (ElSohly et al., 2016). This rise in potency has raised alarm among healthcare professionals as higher THC levels may intensify the overstimulation of cannabinoid receptors, increasing the likelihood of negative side effects like CHS.
Greater Awareness
Another reason for rising CHS cases is improved awareness among medical professionals. Emergency rooms are becoming better equipped to identify CHS. Physicians now routinely inquire about cannabis use when patients present with unexplained vomiting or severe abdominal pain—a critical step in making this diagnosis.
Overdosing on Weed: Is It Related to Cannabinoid Hyperemesis Syndrome?
While marijuana is often viewed as a relatively low-risk substance, heavy or prolonged use can lead to serious health complications, including Cannabinoid Hyperemesis Syndrome (CHS). What some people describe as “overdosing on weed” usually refers to consuming more THC than the body can tolerate, resulting in symptoms such as severe anxiety, panic, confusion, rapid heart rate, nausea, vomiting, or extreme drowsiness. Although a THC overdose is generally not fatal, it can be distressing enough to require emergency medical care.
CHS is different from an acute THC overdose. Rather than occurring after a single episode of excessive cannabis use, CHS typically develops after months or years of frequent, long-term marijuana use. As cannabis products continue to increase in potency and popularity with young adults, healthcare providers are seeing more cases of CHS among individuals who regularly use high-THC flower, concentrates, or edibles.
One of the most important differences is that CHS symptoms often continue to return until cannabis use stops completely. While temporary treatments such as IV fluids, anti-nausea medications, or hot showers may provide short-term relief, lasting improvement generally requires abstaining from cannabis. Recognizing the connection between chronic marijuana use and recurring gastrointestinal symptoms is an important step toward receiving an accurate diagnosis and appropriate care.
If long-term marijuana use has begun affecting your health, it’s important to know that help is available. What matters most is recognizing the signs, seeking medical guidance, and taking the first steps toward healing. With the right support, it is possible to manage CHS symptoms, address problematic cannabis use, and begin building a healthier future.
When to Seek Help for CHS
If you or a loved one is experiencing symptoms that align with cannabinoid hyperemesis syndrome ICD 10, seeking medical care can relieve distress and prevent complications like dehydration and malnutrition.
At Enlightened Recovery Detox, we offer compassionate, medically supervised detox programs tailored to those ready to begin healing from cannabis-related challenges. Our team provides 24/7 care to help your body stabilize while prioritizing your comfort and dignity.
What We Offer:
- Holistic Care: Support for your mind, body, and soul, including nutrition, hydration, and emotional counseling.
- Personalized Treatment Plans: Your recovery plan is crafted based on your specific symptoms and goals, ensuring care that feels aligned with your unique journey.
- Next-Step Support: Beyond detox, we’ll help you transition into aftercare or long-term rehabilitation, so you can continue building a healthy, fulfilling life.
Moving Away From Chronic Cannabis Abuse & Toward Health and Clarity
CHS can feel confusing and even overwhelming, but it’s a condition that can be treated. You don’t have to face it alone. Whether you’re seeking relief for persistent nausea and vomiting or searching for answers about how cannabis use might affect your health, we’re here to guide and support you every step of the way.
At Enlightened Recovery Detox, we believe in the power of personalized care, connection, and hope. Together, we can help you restore your body, mind, and spirit as you move toward long-term health and well-being.
References
ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in cannabis potency over the last 2 decades (1995–2014): Analysis of current data in the United States. Biological Psychiatry, 79(7), 613–619. Retrieved from https://pubmed.ncbi.nlm.nih.gov/26836462/
Sorensen, C. J., DeSanto, K., Borgelt, L., Phillips, K. T., & Monte, A. A. (2017). Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment – A Systematic Review. Journal of Medical Toxicology. Retrieved from https://www.cureus.com/articles/7957-the-incidence-of-cannabinoid-hyperemesis-syndrome-in-a-community-hospital-emergency-department.